Larvol Delta - A-Study-to-Evaluate-Safety-Tolerability-and-Reactogenicity-of-an-RBDFcbased-Vaccine-to-Prevent-COVID19

baiya SARS-CoV-2 vax 1 - Baiya Phytopharm, Chulalongkorn University

http://clinicaltrials.gov/ct2/show/NCT04953078

Feb 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev